127 related articles for article (PubMed ID: 31235371)
1. Cervical Cancer Screening in Immunocompromised Women.
McClymont E; Lee M; Elwood C; Mitchell-Foster S; van Schalkwyk J; Ogilvie G; Money D
J Obstet Gynaecol Can; 2019 Aug; 41(8):1177-1180. PubMed ID: 31235371
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
[TBL] [Abstract][Full Text] [Related]
3. Evidence that supports policies to delay cervical screening until after age 25 years.
Dickinson JA; Ogilvie G; Van Niekerk D; Popadiuk C
CMAJ; 2017 Mar; 189(10):E380-E381. PubMed ID: 28385818
[No Abstract] [Full Text] [Related]
4. Screening Women at High Risk for Cervical Cancer: Special Groups of Women Who Require More Frequent Screening.
Vegunta S; Files JA; Wasson MN
Mayo Clin Proc; 2017 Aug; 92(8):1272-1277. PubMed ID: 28778260
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of abnormal cervical cancer screening outcomes among screening-compliant women in the United States.
Chido-Amajuoyi OG; Shete S
Am J Obstet Gynecol; 2019 Jul; 221(1):75-77. PubMed ID: 31078510
[No Abstract] [Full Text] [Related]
6. (Pre)malignancies of the female anogenital tract in renal transplant recipients.
Meeuwis KA; van Rossum MM; Hoitsma AJ; de Hullu JA
Transplantation; 2011 Jan; 91(1):8-10. PubMed ID: 21452406
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and determinants of cervical cancer screening with a combination of cytology and human papillomavirus testing.
Fokom Domgue J; Cunningham SA; Yu RK; Shete S
Ann Epidemiol; 2019 Aug; 36():40-47. PubMed ID: 31320153
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening in immunocompromised women.
Nguyen ML; Flowers L
Obstet Gynecol Clin North Am; 2013 Jun; 40(2):339-57. PubMed ID: 23732035
[TBL] [Abstract][Full Text] [Related]
9. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
[TBL] [Abstract][Full Text] [Related]
10. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2012 Jun; 156(12):880-91, W312. PubMed ID: 22711081
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening in older women.
Dallred C
Clin J Oncol Nurs; 2006 Feb; 10(1):31-3. PubMed ID: 16482725
[No Abstract] [Full Text] [Related]
12. Cervical cancer screening uptake in women aged between 15 and 64 years in Mozambique.
Brandão M; Tulsidás S; Damasceno A; Silva-Matos C; Carrilho C; Lunet N
Eur J Cancer Prev; 2019 Jul; 28(4):338-343. PubMed ID: 30020115
[TBL] [Abstract][Full Text] [Related]
13. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
[TBL] [Abstract][Full Text] [Related]
14. Abnormal cervical cytology in bone marrow transplant recipients.
Sasadeusz J; Kelly H; Szer J; Schwarer AP; Mitchell H; Grigg A
Bone Marrow Transplant; 2001 Aug; 28(4):393-7. PubMed ID: 11571513
[TBL] [Abstract][Full Text] [Related]
15. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
[TBL] [Abstract][Full Text] [Related]
16. Changes on the horizon for cervical cancer screening.
Isidean SD; Shinder GA
Prev Med; 2017 May; 98():1-2. PubMed ID: 28034732
[No Abstract] [Full Text] [Related]
17. The rationale for implementation of HPV testing in routine cervical screening in Romania.
Iancu LS; Ursu RG
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
[No Abstract] [Full Text] [Related]
18. Rightsizing cervical cancer screening: comment on "Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone".
Sawaya GF
Arch Intern Med; 2010 Jun; 170(11):985-6. PubMed ID: 20548012
[No Abstract] [Full Text] [Related]
19. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
Maura G; Chaignot C; Weill A; Alla F; Heard I
Eur J Cancer Prev; 2018 Sep; 27(5):479-485. PubMed ID: 28368950
[TBL] [Abstract][Full Text] [Related]
20. A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil.
Castilho JL; Levi JE; Luz PM; Cambou MC; Vanni T; de Andrade A; Derrico M; Veloso VG; Grinsztejn B; Friedman RK
BMC Cancer; 2015 Jun; 15():478. PubMed ID: 26100400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
